sorafenib has been researched along with dextrothyroxine in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (dextrothyroxine) | Trials (dextrothyroxine) | Recent Studies (post-2010) (dextrothyroxine) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 7,511 | 855 | 3,349 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, J; Le, W; Li, M; Lu, H; Yuan, Y; Zhang, T; Zhou, L; Zuo, H | 1 |
1 other study(ies) available for sorafenib and dextrothyroxine
| Article | Year |
|---|---|
Ivermectin synergizes sorafenib in hepatocellular carcinoma via targeting multiple oncogenic pathways.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Ivermectin; Liver Neoplasms; Mice; Sorafenib | 2022 |